Regimen Optimization Study
Public ClinicalTrials.gov record NCT02137239. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluation of Acute Rejection Rates in de Novo Renal Transplant Recipients Following Thymoglobulin Induction, CNI-free, Nulojix (Belatacept)-Based Immunosuppression
Study identification
- NCT ID
- NCT02137239
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Enrollment
- 58 participants
Conditions and interventions
Conditions
Interventions
- Thymoglobulin Drug
- Belatacept Drug
- mycophenolate mofetil(MMF) Drug
- Corticosteroids Drug
- Everolimus(EVL) Drug
- Tacrolimus(TAC) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 30, 2015
- Primary completion
- May 1, 2019
- Completion
- May 1, 2019
- Last update posted
- Jun 21, 2021
2015 – 2019
United States locations
- U.S. sites
- 17
- U.S. states
- 15
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| California Institute Of Renal Research | San Diego | California | 92123 | — |
| California Pacific Medical Center | San Francisco | California | 94115 | — |
| University Of Colorado | Aurora | Colorado | 80045 | — |
| Yale University | New Haven | Connecticut | 06519 | — |
| MedStar Georgetown University Hospital | Washington D.C. | District of Columbia | 20007 | — |
| Emory Univeristy | Atlanta | Georgia | 30322 | — |
| University Of Illinois | Chicago | Illinois | 60612 | — |
| Tulane Medical Center | New Orleans | Louisiana | 70112 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Saint Barnabas Medical Center | Livingston | New Jersey | 07039 | — |
| Erie County Medical Center | Buffalo | New York | 14215 | — |
| Wake Forest University School Of Medicine | Winston-Salem | North Carolina | 27157 | — |
| Central PA Transplant Foundation | Harrisburg | Pennsylvania | 17104 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | — |
| University of Virginia | Charlottesville | Virginia | 22908-0709 | — |
| Inova Fairfax Hospital | Falls Church | Virginia | 22042 | — |
| Swedish Medical Center - Swedish Colon and Rectal Clinic - First Hill (Northwest Colon and Rectal Cl | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02137239, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 21, 2021 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02137239 live on ClinicalTrials.gov.